InflaRx (NASDAQ:IFRX) outlined plans to prioritize development of izicopan, an oral inhibitor of the C5a receptor (C5aR), in ...

Chronic kidney diseases have one thing in common: once they start, regardless of the cause and even if it is treated, they ...

"Net loss was $9.1 million in Q1 '26 compared to net income of $6.1 million," driven by decreasing Auryxia revenues and ...

Scientists have taken a giant leap forward with the development of tiny microneedles designed to detect subtle but critical ...

A hantavirus vaccine is currently in preclinical development, but a publicly available shot is likely years away. Other ...

REVB READ THE FULL REVB RESEARCH REPORT Revelation Biosciences (NASDAQ: REVB) is a potentially high-upside clinical-stage biotechnology company focused on immune modulation and inflammatory disease ...

Marjorie Taylor Greene and other conservative commentators have claimed that Moderna is developing a hantavirus mRNA vaccine.

Interim biomarker-rich Phase 1 data for JADE101 to be featured in an oral session at the 63rd European Renal Association Congress Phase 2 trial of JADE101 in IgA nephropathy patients expected to begin ...

A largely overlooked structure inside our cells may play a crucial role in how the brain forms, offering new insight into ...

Organoids are miniature tissue or organ models formed by stem cells (including pluripotent stem cells, tissue-specific adult ...

The presence of a slight fever, body aches, fatigue, or nausea is usually nothing to be concerned about initially. However, ...